|
HS Code |
261409 |
| Product Name | 1-Bromo-5-(4-Methoxyphenyl)Pentane |
| Molecular Formula | C12H17BrO |
| Molecular Weight | 257.17 g/mol |
| Cas Number | 749926-74-1 |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | Estimated ~350°C at 760 mmHg |
| Density | Approx. 1.27 g/cm³ |
| Solubility In Water | Insoluble |
| Flash Point | Estimated >100°C |
| Purity | Typically ≥98% |
| Smiles | COC1=CC=C(C=C1)CCCCCBr |
| Inchi | InChI=1S/C12H17BrO/c1-14-12-6-4-11(5-7-12)9-3-2-8-10-13/h4-7H,2-3,8-10H2,1H3 |
| Storage | Store at 2-8°C, protected from light and moisture |
| Refractive Index | Estimated 1.520-1.540 |
As an accredited 1-Bromo-5-(4-Methoxyphenyl)Pentane factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, tightly sealed with a secure cap, labeled "1-Bromo-5-(4-Methoxyphenyl)Pentane, 25g", with safety and handling information. |
| Shipping | The chemical **1-Bromo-5-(4-Methoxyphenyl)pentane** is shipped in tightly sealed, labeled containers compliant with international transport regulations. It is handled as a hazardous material, requiring protective packaging to prevent leaks and environmental exposure. Shipping is via certified carriers, with accompanying safety data sheets and necessary documentation for safe handling and transit. |
| Storage | 1-Bromo-5-(4-Methoxyphenyl)pentane should be stored in a tightly sealed container, away from light, heat, and sources of ignition. Store in a cool, dry, and well-ventilated area, preferably in a designated chemical storage cabinet. Avoid contact with oxidizing agents and bases. Properly label the container and ensure compliance with local regulations for hazardous chemical storage. |
Applications of 1-Bromo-5-(4-Methoxyphenyl)Pentane in Industrial Manufacturing1-Bromo-5-(4-Methoxyphenyl)Pentane serves as a specialized intermediate in several sectors, primarily utilized for its reactivity in organic synthesis, especially in pharmaceutical, agrochemical, and advanced material industries. As a direct manufacturer, we supply this intermediate to clients integrating it into distinct downstream production streams, each demanding stringent compliance and consistent quality. 1. Pharmaceutical Intermediate in CNS Active Compound SynthesisPharmaceutical companies incorporate 1-Bromo-5-(4-Methoxyphenyl)Pentane as a key building block in the synthesis of central nervous system (CNS) drug candidates. Medicinal chemistry teams use it for the alkylation steps in creating diarylalkane structures, crucial for neurological agents. Manufacturing proceeds under validated batch processes that include nucleophilic substitution reactions, typically followed by purification through chromatography. Quality control teams monitor trace impurities according to international pharmacopoeial requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Selective Herbicide SynthesisMajor agrochemical formulators utilize this intermediate during the production of novel phenolic herbicides. Plant protection product manufacturers perform alkyl substitution reactions, embedding the methoxyphenyl moiety into longer aliphatic chains. This step often precedes sulfonation or amide coupling, with process chemists monitoring conversion ratios to optimize active ingredient synthesis. Each batch undergoes trace residue analysis to meet EU and EPA limits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Advanced Material FunctionalizationPolymer and advanced materials producers use the compound to functionalize specialty monomers, improving compatibility and performance in engineered thermoplastics and coatings. Technicians conduct nucleophilic aromatic substitution or amine coupling steps under inert atmosphere to prevent side-reactions, strictly controlling kinetics during upscaling to pilot or full industrial reactor size. Analytical teams verify incorporation using NMR and GC-MS before advancing to compounding or extrusion. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Building Block in Fragrance Intermediate SynthesisFragrance compound manufacturers apply this material as a key intermediate in preparing complex organic molecules with substituted methoxyphenyl chains, especially in high-end fine fragrance accords. Synthetic chemists utilize the compound for Friedel–Crafts and alkylation reactions, ensuring strict reaction temperature and pH controls to prevent side product formation. QC departments monitor for organoleptic purity and compliance with international flavor and fragrance standards before formulation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Controlled Substance Intermediate in Research Chemical SynthesisAccredited research laboratories and reference standard producers employ this intermediate in the development of analogues for controlled substances—always in compliance with strict legal and safety regulations. Laboratory chemists implement it in multi-step syntheses, focusing on purity and traceable handling. All uses require batch tracking, personnel authorization, and secure inventory systems to align with regional law enforcement policies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-Bromo-5-(4-Methoxyphenyl)Pentane prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Within our facility, every chemical we produce reflects years of close work with researchers and process chemists. 1-Bromo-5-(4-methoxyphenyl)pentane stands out as a versatile intermediate that bridges the worlds of pharmaceuticals, ligand design, and advanced polymer precursors. Throughout my years running kilo-scale reactions and scaling bench-top syntheses, I have seen firsthand the frustration that comes from inconsistent purity, unpredictable reactivity, or troublesome side reactions in these types of specialty alkyl bromides. These are not just minor inconveniences. They often derail valuable development projects or require expensive purification steps. We’ve focused on producing this compound using methods that target high selectivity and minimize common contaminants like dibrominated side products, oxidative byproducts, or unreacted starting alcohols.
This molecule features a linear pentane chain topped with a methoxyphenyl group and a terminal bromide. In the lab, chemists value the bromoalkane unit for its reliable reactivity in SN2 displacement, coupling strategies, and as a masked amine or alcohol precursor. Several years ago, we shifted to a controlled low-temperature bromination process, dialing in key parameters to avoid overbromination and aromatic substitution. Lab-scale chemists usually deal with milligram to gram scales. Our unit runs both multi-kilo and pilot lots, which require everything to line up: solvent choice, stir rates, quench protocols, and product isolation—each tuned to keep the methoxy group from splitting off or the side chain from oxidizing.
We filter, dry, and distill under reduced pressure to avoid heat-induced rearrangements, which helps protect downstream transformations from contaminants that might poison catalysts or confuse yield calculations. Each lot is tracked not just by GC or HPLC but by NMR for trace para-substituted aromatic impurities—anyone scaling up diarylalkane syntheses or advanced ligands can appreciate why that matters.
Our clients—process chemists in pharma, material science R&D, and graduate-level organics—apply this intermediate as an alkylating agent on oxygen, nitrogen, carbon, or sulfur nucleophiles. The bromide leaves as a tidy leaving group in both mild and basic conditions. In some cases, I’ve heard from bench chemists who rely on it to alkylate phenols for selective etherification without scrambling the aromatic substituents. One advantage comes from that methoxy group: electronically, it tempers the ring, nudging the reactivity in favor of controlled monoalkylation instead of messy side reactions.
Some applications require solid-phase attachment for combinatorial libraries. Others transform this building block into pharmacophore-rich analogues for CNS drug research. In each case, the quality of the starting bromoalkane makes downstream work either straightforward or a minefield. There was a large-scale customer who tested a bulk shipment in their heterocycle bench and found the ratio of side products had dropped significantly. They reduced their purification steps by one full column, which for a 10-kg synthesis translates to meaningful cost savings and less solvent waste.
Chemists sometimes lump all bromoalkanes together, but this compound’s aromatic-methoxy substitution sets it apart. Standard n-pentyl bromide lacks the reactivity tuning required for these applications. Brominated aromatics like p-bromoanisole offer different profiles but can’t deliver the flexible chain length that attaches selectively to nucleophilic sites. 1-Bromo-5-(4-methoxyphenyl)pentane brings both—a phenyl group with an electron-donating methoxy, and a pentyl tether for selective, controlled functionalization. Over the years, customers looking to synthesize complex molecules with specific pharmacophore spacing turn to this product where more basic bromoalkanes would fail or deliver too many isomers.
We refine our process to curb halogen exchange or internal cyclization, which plagues some imports from open-market vendors. In our QC, we check for moisture content and halide purity—two factors that affect both the shelf stability and the reliability of downstream reactions. Chemists tell us that material from less specialized sources can force them to redistill or even run extra analysis to confirm identity; with carefully monitored process engineering, we take that uncertainty off the table.
Every batch starts with high-grade starting alcohols, which we source after verifying identity and impurity profile by NMR and GC. Our bromination process uses phosphorus tribromide (PBr3) under argon. My team has learned the hard way that even fractional excess or trace water changes the outcome. Each reaction is monitored by TLC and in-line sampling. After careful quenching and neutralization, the crude product is treated with chelating agents to strip off phosphate residues, which otherwise complicate purification.
Our skilled technicians work under inert atmosphere right through distillation. Years of scale-ups have taught us that gentle heating and careful fractionation go much further than any amount of post-synthesis clean-up. The compound is packed in gas-flushed, light-blocking bottles to offset light-induced degradation, preserving its sharpness for months in cold storage.
We developed these steps by working side-by-side with our customers, discussing not just paperwork specs but real-world challenges: What happens when cleaner product lets a process finish faster? How does trace impurity content influence catalysis or functional group manipulations? By focusing on fact-based feedback, we shape our process around what chemists actually see in the lab—not on abstract targets.
Over the last decade, the field has pushed further into late-stage functionalization, combinatorial chemistry, and new routes to bioactive agents. Demand for nuanced, consistent bromoalkanes comes not from wish lists but from practical headaches: batch-to-batch drift, variable byproduct ratios, or instability during storage and handling. We’ve worked with several pharmaceutical partners facing pilot-scale issues—loss of activity, foul-smelling polybrominated byproducts, or mysterious TLC spots that do not correspond to any known intermediate.
We addressed these issues with concrete steps. On the line, our trained staff keep water and oxygen off every batch; we finish each synthesis with a triple check: NMR confirmation, GC for halocarbon distribution, and Karl Fischer titration for water. When one customer tested our product against three competing lots, their catalyzed amine coupling reaction yielded a clean, single product spot with only one purification step. No “sticky” decomposed bromoalkane, no aromatic rearrangement peak. The difference showed up in both process time (a full working day saved) and product yield (about 8% higher compared to their previous supplier). These aren’t just numbers—they change the cost and timeline of developing new molecules.
Having handled thousands of liters of reactive organobromides, I know accidents happen when corners get cut. 1-Bromo-5-(4-methoxyphenyl)pentane benefits from standard organobromide handling: cool storage, air-free sealing, and minimized light exposure. We fill to-order in volume-matched bottles, ensuring less headspace to cut down on potential oxidation. Temperature swings tend to speed up slow decomposition over months; steady refrigeration preserves reactivity better than room temp storage, especially during humid summers.
We train our warehouse team and shipping partners on chemical-specific practices: double-sealed bottles, batch records attached to every shipment, and immediate logging upon receipt at the customer’s dock. These details matter. Unexplained bottle pressure, yellowing, or low yield tests trace directly to mistakes made in filling or shipment. Tight controls minimize headaches and keep research moving.
Customers often ask if the product crystallizes on cooling, or how to minimize waste on large runs. Our experience shows it stays a mobile liquid down to moderate refrigeration, making it easy to extract or portion out in process reactors. For bigger reactors, direct transfer from cold storage minimizes risk. Fine details like these go unmentioned on spec sheets but come straight from daily handling and real-world troubleshooting.
Chemists working on new synthetic routes or scaling up existing protocols need reliable input chemicals to avoid surprise bottlenecks. We’ve seen projects fail in early optimization because the bromoalkane starting material changed from pilot batch to commercial run—trace contaminants made scale-up unpredictable or, worse, blocked project approval. By following strict process controls and offering analytical trace data with every batch, we turn our customers’ synthetic plans from “trial and error” into robust, reproducible procedures.
Bespoke specifications don’t faze us. Process chemists sometimes request specific halide content, alternate solvents, or need advice for awkward workups. Years of direct technical support have taught us to listen first—learning what a customer actually requires—whether for a small run requiring super-critical purity or a multi-ton campaign with broader spec windows. We have helped chemical R&D teams tune their own alkylation steps, adjusting equivalents or mixing sequences based on side-product data we share.
Customers often compare 1-Bromo-5-(4-methoxyphenyl)pentane to similar bromoalkanes or longer-chain analogs. Experience shows you don’t just swap one for another: the electronic influence of that methoxy group alters reaction kinetics, and the pentane spacer affects how the aromatic ring sits during alkylation. Swapping in a more basic bromopentane, for example, can amplify side-chain elimination troubles or trigger unwanted cyclizations. Throughout hundreds of syntheses and conversations, we keep returning to a simple truth: precision in starting materials buys downstream efficiency.
Decades in manufacturing taught us that environmental stewardship isn’t an afterthought. We developed a closed system for handling and quenching phosphorus-containing byproducts—this preserves operator safety and keeps compliance with waste laws. Organobromides can pose challenges in effluent management; we run our distillates through scrubbers and carbon filtration, always logging waste streams and documenting every lot’s output. This is more than box-ticking. We’ve seen how low-quality batches—sometimes imported without oversight—create headaches for users trying to trace environmental or health issues back to contaminated intermediates.
By focusing on consistent production and transparent documentation, we support customers facing their own regulatory hurdles, making audits and filings less painful. Providing material what-it’s-supposed-to-be-gives assurance not just for bench chemistry, but for scale-up and eventual approval in pharmaceutical or material applications.
Every successful synthesis hinges on reproducible raw materials. I recall early efforts before we dialed in our process. Reaction scales fluctuated day to day, purity shifted lot to lot, and troubleshooting took hours away from productive lab time. Today, every new run benefits from incremental process improvements built into our procedures. Real-time feedback from customers guides tweaks in our protocols—sometimes a minor adjustment in drying time or distillation cut points raises reliability in a measurable way. These lessons accumulate, forming a track record of steady, knowable output.
By investing in in-house analytics and transparent reporting, we help demystify why certain synthetic plans fail with generic chemicals. Chemists know that details—subtle variations in water content, small differences in aromatic substitution, even minor storage-induced color changes—can mean the difference between a functional product and an unreliable mess. We eliminate as many of those variables as we can, lowering the risk in every batch used downstream.
There’s a practical satisfaction when a customer calls up months after a delivery, asking for the same batch number for their next scale-up, or requesting copies of our chromatograms. That loyalty isn’t bought with sales talk. It comes from steady results and honest conversations about what went right—and what could go better. In this way, partnerships built around 1-Bromo-5-(4-methoxyphenyl)pentane extend beyond transaction. They are hallmarks of mutual respect and technical understanding.
Many of our clients operate at the cutting edge of new molecule development, facing compressed timelines and rigorous quality standards. We know delays and purity issues can cost weeks or force costly reruns. By working with R&D teams directly—sharing process notes, answering technical queries, discussing real-world performance—we position ourselves not as a vendor, but as a flexible partner committed to advancing their projects.
Synthetic targets grow more ambitious every year, with complex molecular scaffolds and late-stage diversifications placing higher demands on precursor reliability. We see these trends firsthand in our order logs and in conversations with project leads planning their next campaigns. Anticipating this rising need for both purity and documented process control, our technical group stays focused on adopting best-in-class analytical techniques, wider traceability in raw material sourcing, and more dialogue with users facing novel synthetic challenges.
Sourcing intermediates like 1-Bromo-5-(4-methoxyphenyl)pentane involves more than just filling orders. It demands daily attention to subtle process details—moisture exclusion, batch documentation, close control of synthetic variables. Years of refining these steps have taught us that each lot can play a pivotal role in the outcome of high-profile research projects, process optimizations, and commercial launches.
For those in the field seeking a reliable source for 1-Bromo-5-(4-methoxyphenyl)pentane, experience shows the difference comes down to steady focus, tested protocols, and a willingness to engage with customers’ real-life problems—not just paperwork. From our manufacturing floor to your lab bench, the value lies not in claims but in the tangible benefits seen run after run, as well-managed intermediates make ambitious chemistry possible.